Diabetes and Vascular Calcification

Vascular calcification had been accepted as a passive, degenerative process, but recent findings suggested that it is actively regulated like osteogenesis. In addition, vascular calcification is roughly classified into two types: intimal arterial calcific

  • PDF / 290,875 Bytes
  • 10 Pages / 439.37 x 666.142 pts Page_size
  • 1 Downloads / 187 Views

DOWNLOAD

REPORT


Diabetes and Vascular Calcification Katsuhito Mori and Masaaki Inaba

Abstract  Vascular calcification had been accepted as a passive, degenerative process, but recent findings suggested that it is actively regulated like osteogenesis. In addition, vascular calcification is roughly classified into two types: intimal arterial calcification (IAC) and medial arterial calcification (MAC). IAC is usually associated with atherosclerosis, whereas MAC is often associated with aging, diabetes, and chronic kidney disease. Although MAC does not directly cause stenotic or occlusive lesions, it may exacerbate arterial stiffness with significant hemodynamic changes, resulting in cardiovascular mortality. Transdifferentiation of vascular smooth muscle cells (VSMCs) and changes in extracellular matrix (ECM), which are mainly due to elastin degradation, are involved in the onset and progression of MAC. In particular, runt-related transcription factor 2 (Runx2) seems to play a critical role in the transformation of VSMCs from a vascular contractile phenotype into an osteoblast-like phenotype. The presence of diabetes accelerates both VSMC transdifferentiation through the upregulation of Runx2 and ECM changes by metalloproteinase-­induced elastin degradation. Fetuin-A can act as not only an inducer of insulin resistance but also as an inhibitor of ectopic calcification through the formation of calciprotein particles (CPPs). Recently, it has been hypothesized that overproduction of CPPs could cause vascular damage, including vascular calcification. Since fetuin-A is involved in both diabetes and vascular calcification, precise investigation of CPPs may give new insights in this field. Keywords  Diabetes • Vascular calcification • Medial arterial calcification • Smooth muscle cells • Fetuin-A

K. Mori, M.D. (*) • M. Inaba The Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka 545-8585, Japan e-mail: [email protected] © Springer Nature Singapore Pte Ltd. 2018 S.-i. Yamagishi (ed.), Diabetes and Aging-related Complications, https://doi.org/10.1007/978-981-10-4376-5_5

59

60

K. Mori and M. Inaba

5.1  Introduction Diabetes mellitus is highly prevalent in the world and is, inarguably, one of the representative diseases that cause vascular complications. Appropriate treatment of diabetes, especially if with concomitant cardiovascular disease, is a pressing issue in modern society. Historically, understanding the mechanism of atherosclerosis induced by diabetes was the main issue in this field. For example, the formation of occlusive lesions in an atherosclerotic plaque, such as in acute coronary syndrome (ACS), had been focused on. However, emerging evidence suggested that alteration of arterial stiffness, or arteriosclerosis, which is neither stenotic or thrombogenic, plays a critical role in cardiovascular mortality. Vascular calcification, especially in the media, has provided many clues to the significance of hemodynamic chang